{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:43Z","timestamp":1787026843495,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neurogenic orthostatic hypotension (nOH), a common non-motor feature of Parkinson\u2019s disease (PD), is defined as a sustained drop in blood pressure (BP) upon standing due to autonomic dysfunction. Although prior studies support an association between nOH and cognitive impairment, its longitudinal impact on cognitive decline in PD remains insufficiently explored. We aimed to determine to what extent baseline nOH is associated with an accelerated decline in global and exploratory domain-specific cognitive functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective longitudinal cohort study was conducted using clinical data from patients with PD evaluated at the University of California San Diego movement disorders clinics between 2012 and 2024. Participants were classified as having nOH (nOH+) or without nOH (nOH\u2212) based on initial orthostatic BP measurements (\u226520 mmHg systolic BP and\/or \u226510 mmHg diastolic BP reduction within 3 minutes of standing, with a blunted heart rate response [\u0394HR\/\u0394SBP] &amp;lt; 0.5 bpm\/mmHg). Cognitive performance was assessed using the Montreal Cognitive Assessment (MoCA), including total scores and domain-specific subscores. Longitudinal changes in cognitive function were modeled using linear mixed-effects models, adjusting for time, nOH status, age, sex, and their interaction. Motor and non-motor symptom progression was evaluated using the MDS-UPDRS Parts I\u2013III.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with nOH at the first visit showed faster decline in total MoCA scores (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.57, SE\u202f=\u202f0.15,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), reflecting declines in abstraction (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.15, SE\u202f=\u202f0.05,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01), attention (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.13, SE\u202f=\u202f0.04,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.01), delayed recall (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.18, SE\u202f=\u202f0.06,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), executive function (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.16, SE\u202f=\u202f0.05,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), language (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.14, SE\u202f=\u202f0.05,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), and orientation (Interaction\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.17, SE\u202f=\u202f0.06,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) subscores. No significant time \u00d7 nOH interaction was observed for MDS-UPDRS Parts I-III (all\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;gt;\u202f0.6), indicating comparable rates of motor and nonmotor symptom progression between nOH+ and nOH\u2212 groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this single-center, real-world retrospective cohort, the presence of baseline nOH was associated with a more rapid decline in cognitive function. These findings highlight the potential importance of early autonomic assessment in PD and warrant further investigation in larger, multi-center studies to determine generalizability and to better understand the underlying mechanisms contributing to cognitive deterioration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1783953","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:12:03Z","timestamp":1773335523000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of neurogenic orthostatic hypotension with cognitive decline in Parkinson\u2019s disease: a longitudinal cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Neda","family":"Bagheri","sequence":"first","affiliation":[{"name":"School of Medicine, University of California, San Diego","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Longardner","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of California","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Coughlin","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of California","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease","volume":"26","author":"Martinez-Martin","year":"2011","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e2194","DOI":"10.1212\/wnl.0000000000200113","article-title":"Association of motor and nonmotor symptoms with health-related quality of life in a large online cohort of people with Parkinson disease","volume":"98","author":"Bock","year":"2022","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1007\/s00415-022-11221-9","article-title":"Differential impact of individual autonomic domains on clinical outcomes in Parkinson\u2019s disease","volume":"269","author":"Longardner","year":"2022","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jamda.2023.10.002","article-title":"Associations of orthostatic hypotension and orthostatic intolerance with domain-specific cognitive decline in patients with early Parkinson\u2019s disease: an 8-year follow-up","volume":"25","author":"Choi","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2076942","DOI":"10.1155\/2020\/2076942","article-title":"Cognition deficits in Parkinson's disease: mechanisms and treatment","volume":"2020","author":"Fang","year":"2020","journal-title":"Parkinson's Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2017.09.028","article-title":"Orthostatic hypotension associated with executive dysfunction in mild cognitive impairment","volume":"382","author":"Bocti","year":"2017","journal-title":"J Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10286-021-00841-2","article-title":"Independent effect of neurogenic orthostatic hypotension on mild cognitive impairment in Parkinson\u2019s disease","volume":"32","author":"Kang","year":"2022","journal-title":"Clin Auton Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fneur.2020.00897","article-title":"Orthostatic hypotension is associated with cognitive decline in Parkinson\u2019s disease","volume":"11","author":"Longardner","year":"2020","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10072-022-06537-3","article-title":"A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson's disease","volume":"44","author":"Loureiro","year":"2023","journal-title":"Neurolog Sci: Official J Italian Neurolog Society Italian Society Clin Neurophysiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"522531","DOI":"10.1002\/ana.25170","article-title":"Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies","volume":"83","author":"Norcliffe-Kaufmann","year":"2018","journal-title":"Ann Neurol"},{"key":"ref15","volume-title":"R: A language and environment for statistical computing","year":"2025"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/rj-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sj\u00f6berg","year":"2021","journal-title":"R J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","article-title":"Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American autonomic society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European academy of neurology (EAN) and the European Society of Hypertension (ESH)","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clinical Autonomic Res: Official J Clinical Autonomic Res Society"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.26632","article-title":"Orthostatic hypotension and cognitive impairment in Parkinson\u2019s disease: causation or association?","volume":"31","author":"McDonald","year":"2016","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14802\/jmd.13006","article-title":"Orthostatic and supine blood pressures are associated with white matter hyperintensities in Parkinson disease","volume":"6","author":"Oh","year":"2013","journal-title":"J Movement Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e814","DOI":"10.1212\/WNL.0000000000012342","article-title":"Association of Orthostatic Hypotension with Cerebral Atrophy in patients with Lewy body disorders","volume":"97","author":"Pilotto","year":"2021","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.parkreldis.2016.04.026","article-title":"Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease","volume":"28","author":"Erro","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/jnnp-2016-314123","article-title":"'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in \u03b1-synucleinopathies?","volume":"87","author":"Udow","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","article-title":"Neurogenic orthostatic hypotension and supine hypertension in Parkinson\u2019s disease and related synucleinopathies: prioritization of treatment targets","volume":"15","author":"Espay","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/jcm14020630","article-title":"Neurogenic orthostatic hypotension in Parkinson\u2019s disease\u2014a narrative review of diagnosis and management","volume":"14","author":"Grosu","year":"2025","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1212\/CPJ.0000000000200068","article-title":"Orthostatic hypotension in Parkinson\u2019s disease: what is new?","volume":"12","author":"Lamotte","year":"2022","journal-title":"Neurol Clin Pract"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e16061","DOI":"10.1111\/ene.16061","article-title":"Levodopa-induced orthostatic hypotension in parkinsonism: a red flag of autonomic failure","volume":"31","author":"Cani","year":"2024","journal-title":"Eur J Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10286-024-01024-5","article-title":"Effect of levodopa on postural blood pressure changes in Parkinson disease: a randomized crossover study","volume":"34","author":"Earl","year":"2024","journal-title":"Clinical Autonomic Res: Official J Clinical Autonomic Res Society"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.02.008","article-title":"Domain-specific accuracy of the Montreal cognitive assessment subsections in Parkinson's disease","volume":"38","author":"Hendershott","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.25070","article-title":"Changes on brief cognitive instruments over time in Parkinson's disease","volume":"27","author":"Lessig","year":"2012","journal-title":"Movement Disord: Official J Movement Disorder Society"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1783953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:12:04Z","timestamp":1773335524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1783953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":34,"alternative-id":["10.3389\/fneur.2026.1783953"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1783953","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"article-number":"1783953"}}